Pediatrix Medical GroupFRA:PDC -0.94%57 Days Payable is 8.58 as of Mar. 2026, which is 10% below its 10-year median of 9.50. GuruFocus rates FRA:PDC with a GF Score™ of 57/100 and a GF Value™ of €11.17 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Pediatrix Medical Group ranks worse than 92.76% on this metric.
The historical rank and industry rank for Pediatrix Medical Group's Days Payable or its related term are showing as below:
FRA:PDC'
s Days Payable Range Over the Past 10 Years
Min: 4.28 Med: 9.5 Max: 13.52
Current: 9.9
During the past 13 years, Pediatrix Medical Group's highest Days Payable was 13.52. The lowest was 4.28. And the median was 9.50.
FRA:PDC's Days Payable is ranked worse than 92.76% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs FRA:PDC: 9.90
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs SGRY, ADUS, SNDA: Days Payable Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pediatrix Medical Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a Days Payable of 8.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pediatrix Medical Group and its competitors. This is 10% below median its historical median of 9.50. Over the past decade, Pediatrix Medical Group's Days Payable has ranged from 4.28 to 13.52. According to the industry distribution chart, Pediatrix Medical Group ranks #564 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 92.8%.
Is Pediatrix Medical Group's Days Payable too high?
Pediatrix Medical Group's current Days Payable of 8.58 is 10% below median its 10-year median of 9.50. Over the past 10 years, this metric has ranged from a low of 4.28 to a high of 13.52. The Healthcare Providers & Services industry median Days Payable is 58.08. Pediatrix Medical Group's value of 8.58 is 85.2% below this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #564 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Days Payable compare to SGRY and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #564 out of 608 companies for Days Payable. This places Pediatrix Medical Group in the lower half of its industry. The industry median Days Payable is 58.08. Pediatrix Medical Group's value of 8.58 is 85.2% below this benchmark. Historically, Pediatrix Medical Group's own Days Payable has ranged from 4.28 to 13.52 over the past decade. While the company's 10-year median is 9.50 vs. the industry median of 58.08, Pediatrix Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Days Payable of 8.58 is 85.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Days Payable is 8.58, which is 10% below median its own 10-year median of 9.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.17, compared to a current price of €21.00 — trading 88% above its estimated fair value. The current Days Payable is 8.58, which is 10% below median its 10-year median of 9.50 and 85.2% below the Healthcare Providers & Services industry median of 58.08. Pediatrix Medical Group's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Days Payable is 8.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €21.00 is trading 88% above its estimated GF Value™ of €11.17.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Days Payable: 8.58 (10% below median its 10-year median of 9.50)
GF Value™: €11.17 vs. price of €21.00 (88% above fair value)
Industry Position: 85.2% below the Healthcare Providers & Services median (#564 of 608)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
57GF Score
Get the complete analysis for FRA:PDC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
